Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kane Biotech Inc (KNE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3411
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company serves industrial, human and animal healthcare industries. It conducts research and development programs through its on-site CL2 biofilm research laboratory in Canada. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc (KNE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Equity Offering 13
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Debt Offering 23
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc – Key Competitors 24
Kane Biotech Inc – Key Employees 25
Kane Biotech Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 21, 2018: Kane Biotech announces second quarter 2018 financial results 27
May 17, 2018: Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements 29
Mar 21, 2018: Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update 30
Nov 14, 2017: Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options 32
Aug 16, 2017: Kane Biotech – Q2 2017 Financial Results 33
May 17, 2017: Kane Biotech – Q1 2017 Financial Reports 34
Corporate Communications 35
May 22, 2018: Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors 35
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 36
Legal and Regulatory 37
Feb 26, 2018: Kane Biotech Sues Nestle 37
Other Significant Developments 38
Aug 09, 2018: Kane Biotech retains strategic expert in securing non-dilutive funding opportunities in the United States 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Kane Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc, Key Competitors 24
Kane Biotech Inc, Key Employees 25

List of Figures
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China Construction Bank Corp:企業のM&A・事業提携・投資動向
    China Construction Bank Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Construction Bank Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ominto Inc (OMNT):企業の戦略的SWOT分析
    Ominto Inc (OMNT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Galderma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Century Aluminum Co:企業の戦略・SWOT・財務情報
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Clinipace Worldwide Inc:医療機器:M&Aディール及び事業提携情報
    Summary Clinipace Worldwide Inc (Clinipace), formerly Clinipace Inc is a contract research organization that offers drug and medical devices development services. The organization’s services include manufacturing and control, chemistry, biostatistics, clinical monitory, data management, global study …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • PF Atlantic Petroleum (ATLA DKK):石油・ガス:M&Aディール及び事業提携情報
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • China National Petroleum Corporation:企業の戦略・SWOT・財務情報
    China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bm-Bank Public Joint Stock Company:企業の戦略・SWOT・財務分析
    Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report Summary Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Saponia D.D.:企業の戦略・SWOT・財務分析
    Saponia D.D. - Strategy, SWOT and Corporate Finance Report Summary Saponia D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Capsugel Inc:企業の戦略的SWOT分析
    Capsugel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pathway Genomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pathway Genomics Corp (Pathway Genomics) is a healthcare laboratory that offers genetic testing services. Its tests comprise liquid biopsy cancer intercept, true hereditary cancer genetic tests, DNA insight general health and wellness genetic tests, DNA insight pharmacogenomics tests, and ca …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ELITechGroup Inc-医療機器分野:企業M&A・提携分析
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry …
  • WPP plc:企業の戦略・SWOT・財務情報
    WPP plc - Strategy, SWOT and Corporate Finance Report Summary WPP plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆